BACKGROUND: Despite increasing life expectancy (LE), cross-sectional data show widening inequalities in disability-free LE (DFLE) by socioeconomic status (SES) in many countries. We use longitudinal data to better understand trends in DFLE and years independent (IndLE) by SES, and how underlying transitions contribute. METHODS: The Cognitive Function and Ageing Studies (CFAS I and II) are large population-based studies of those aged ≥65 years in three English centres (Newcastle, Nottingham, Cambridgeshire), with baseline around 1991 (CFAS I, n = 7635) and 2011 (CFAS II, n = 7762) and 2-year follow-up. We defined disability as difficulty in activities of daily living (ADL), dependency by combining ADLs and cognition reflecting care required, and SES by area-level deprivation. Transitions between disability or dependency states and death were estimated from multistate models. RESULTS: Between 1991 and 2011, gains in DFLE at age 65 were greatest for the most advantaged men and women [men: 4.7 years, 95% confidence interval (95% CI) 3.3-6.2; women: 2.8 years, 95% CI 1.3-4.3]. Gains were due to the most advantaged women having a reduced risk of incident disability [relative risk ratio (RRR):0.7, 95% CI 0.5-0.8], whereas the most advantaged men had a greater likelihood of recovery (RRR: 1.8, 95% CI 1.0-3.2) and reduced disability-free mortality risk (RRR: 0.4, 95% CI 0.3-0.6]. Risk of death from disability decreased for least advantaged men (RRR: 0.7, 95% CI 0.6-0.9); least advantaged women showed little improvement in transitions. IndLE patterns across time were similar. CONCLUSIONS: Prevention should target the most disadvantaged areas, to narrow inequalities, with clear indication from the most advantaged that reduction in poor transitions is achievable.
BACKGROUND: Despite increasing life expectancy (LE), cross-sectional data show widening inequalities in disability-free LE (DFLE) by socioeconomic status (SES) in many countries. We use longitudinal data to better understand trends in DFLE and years independent (IndLE) by SES, and how underlying transitions contribute. METHODS: The Cognitive Function and Ageing Studies (CFAS I and II) are large population-based studies of those aged ≥65 years in three English centres (Newcastle, Nottingham, Cambridgeshire), with baseline around 1991 (CFAS I, n = 7635) and 2011 (CFAS II, n = 7762) and 2-year follow-up. We defined disability as difficulty in activities of daily living (ADL), dependency by combining ADLs and cognition reflecting care required, and SES by area-level deprivation. Transitions between disability or dependency states and death were estimated from multistate models. RESULTS: Between 1991 and 2011, gains in DFLE at age 65 were greatest for the most advantaged men and women [men: 4.7 years, 95% confidence interval (95% CI) 3.3-6.2; women: 2.8 years, 95% CI 1.3-4.3]. Gains were due to the most advantaged women having a reduced risk of incident disability [relative risk ratio (RRR):0.7, 95% CI 0.5-0.8], whereas the most advantaged men had a greater likelihood of recovery (RRR: 1.8, 95% CI 1.0-3.2) and reduced disability-free mortality risk (RRR: 0.4, 95% CI 0.3-0.6]. Risk of death from disability decreased for least advantaged men (RRR: 0.7, 95% CI 0.6-0.9); least advantaged women showed little improvement in transitions. IndLE patterns across time were similar. CONCLUSIONS: Prevention should target the most disadvantaged areas, to narrow inequalities, with clear indication from the most advantaged that reduction in poor transitions is achievable.
Authors: Maria Gheorghe; Parida Wubulihasimu; Frederik Peters; Wilma Nusselder; Pieter H M Van Baal Journal: Eur J Public Health Date: 2016-04-16 Impact factor: 3.367
Authors: Henrik Brønnum-Hansen; Mikkel Baadsgaard; Mette Lindholm Eriksen; Karen Andersen-Ranberg; Bernard Jeune Journal: Int J Public Health Date: 2015-08-20 Impact factor: 3.380
Authors: Andrew Kingston; Joanna Collerton; Karen Davies; John Bond; Louise Robinson; Carol Jagger Journal: PLoS One Date: 2012-02-15 Impact factor: 3.240
Authors: Fiona E Matthews; Antony Arthur; Linda E Barnes; John Bond; Carol Jagger; Louise Robinson; Carol Brayne Journal: Lancet Date: 2013-07-17 Impact factor: 79.321
Authors: Jenny Head; Holendro Singh Chungkham; Martin Hyde; Paola Zaninotto; Kristina Alexanderson; Sari Stenholm; Paula Salo; Mika Kivimäki; Marcel Goldberg; Marie Zins; Jussi Vahtera; Hugo Westerlund Journal: Eur J Public Health Date: 2019-04-01 Impact factor: 3.367
Authors: Paola Zaninotto; George David Batty; Sari Stenholm; Ichiro Kawachi; Martin Hyde; Marcel Goldberg; Hugo Westerlund; Jussi Vahtera; Jenny Head Journal: J Gerontol A Biol Sci Med Sci Date: 2020-04-17 Impact factor: 6.053
Authors: Holly Q Bennett; Andrew Kingston; Ilianna Lourida; Louise Robinson; Lynne Corner; Carol Brayne; Fiona E Matthews; Carol Jagger Journal: PLoS Med Date: 2022-03-15 Impact factor: 11.613
Authors: Holly Q Bennett; Andrew Kingston; Ilianna Lourida; Louise Robinson; Lynne Corner; Carol Eg Brayne; Fiona E Matthews; Carol Jagger Journal: EClinicalMedicine Date: 2021-07-31
Authors: Md Mijanur Rahman; Carol Jagger; Lucy Leigh; Elizabeth Holliday; Emily Princehorn; Deb Loxton; Paul Kowal; John Beard; Julie Byles Journal: Int J Public Health Date: 2022-08-12 Impact factor: 5.100